US approves Johnson & Johnson COVID-19 vaccine: What are the advantages of the vaccine?
Johnson & Johnson’s vaccine’s efficacy rate came out to be 72% in the clinical trial site in the US. Johnson & Johnson’s COVID-19 vaccine: Johnson & Johnson’s single-shot vaccination against the novel coronavirus SARS-CoV-2 has been approved by the US for emergency use. This means that in the coming week, the rollout of millions of … Read more